The second installment in our two-part article on AIs looks at these agents as potential alternatives to clomiphene citrate and gonadotropins for stimulating fertility in breast cancer survivors.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.